1. Home
  2. NAMSW vs XOSWW Comparison

NAMSW vs XOSWW Comparison

Compare NAMSW & XOSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • XOSWW
  • Stock Information
  • Founded
  • NAMSW N/A
  • XOSWW N/A
  • Country
  • NAMSW Netherlands
  • XOSWW United States
  • Employees
  • NAMSW 29
  • XOSWW 161
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • XOSWW Construction/Ag Equipment/Trucks
  • Sector
  • NAMSW Health Care
  • XOSWW Consumer Discretionary
  • Exchange
  • NAMSW Nasdaq
  • XOSWW Nasdaq
  • Market Cap
  • NAMSW N/A
  • XOSWW N/A
  • IPO Year
  • NAMSW N/A
  • XOSWW 2020
  • Fundamental
  • Price
  • NAMSW $9.00
  • XOSWW $0.03
  • Analyst Decision
  • NAMSW
  • XOSWW
  • Analyst Count
  • NAMSW 0
  • XOSWW 0
  • Target Price
  • NAMSW N/A
  • XOSWW N/A
  • AVG Volume (30 Days)
  • NAMSW N/A
  • XOSWW N/A
  • Earning Date
  • NAMSW N/A
  • XOSWW N/A
  • Dividend Yield
  • NAMSW N/A
  • XOSWW N/A
  • EPS Growth
  • NAMSW N/A
  • XOSWW N/A
  • EPS
  • NAMSW N/A
  • XOSWW N/A
  • Revenue
  • NAMSW N/A
  • XOSWW N/A
  • Revenue This Year
  • NAMSW N/A
  • XOSWW N/A
  • Revenue Next Year
  • NAMSW N/A
  • XOSWW N/A
  • P/E Ratio
  • NAMSW N/A
  • XOSWW N/A
  • Revenue Growth
  • NAMSW N/A
  • XOSWW N/A
  • 52 Week Low
  • NAMSW N/A
  • XOSWW N/A
  • 52 Week High
  • NAMSW N/A
  • XOSWW N/A
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 47.49
  • XOSWW N/A
  • Support Level
  • NAMSW $9.40
  • XOSWW N/A
  • Resistance Level
  • NAMSW $10.14
  • XOSWW N/A
  • Average True Range (ATR)
  • NAMSW 0.44
  • XOSWW 0.00
  • MACD
  • NAMSW -0.12
  • XOSWW 0.00
  • Stochastic Oscillator
  • NAMSW 24.31
  • XOSWW 0.00

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About XOSWW Xos Inc.

Xos Inc is an electric mobility company. It designs and develops fully electric battery mobility systems specifically for commercial fleets. The company's primary focus is on medium- and heavy-duty commercial vehicles that travel on last mile routes. The company leverages its proprietary technologies to provide commercial fleets zero emission vehicles that are easier to maintain and more cost-efficient on a total cost of ownership basis than internal combustion engine and commercial EV counterparts.

Share on Social Networks: